Safety and efficacy of sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation-Reference-Cited by-同舟云学术

Safety and efficacy of sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation

Published:2013-06-13 Issue:4 Volume:27 Page:555-561
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Waghray Abhijeet¹,Balci Bengi¹,El-Gazzaz Galal¹,Kim Richard²,Pelley Robert³,Narayanan Menon KV⁴,Estfan Bassam³,Romero-Marrero Carlos⁴,Aucejo Federico¹

Affiliation:

1. Hepatobiliary and Liver Transplant Surgery; Cleveland Clinic Foundation; Cleveland; OH; USA

2. Gastroenterology Oncology; H. Lee Moffitt Cancer Center and Research Institute; Tampa; FL; USA

3. Solid Tumor Oncology; Cleveland Clinic Foundation; Cleveland; OH; USA

4. Gastroenterology and Hepatology; Cleveland Clinic Foundation; Cleveland; OH; USA

Publisher

Wiley

Subject

Transplantation

Reference24 articles.

1. Estimating the world cancer burden: Globocan 2000;Parkin;Int J Cancer,2001

2. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance;Sangiovanni;Gastroenterology,2004

3. Rising incidence of hepatocellular carcinoma in the United States;El Serag;N Engl J Med,1999

4. Hepatocellular carcinoma: recent trends in the United States;El Serag;Gastroenterology,2004

5. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis;Mazzaferro;N Engl J Med,1996

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma;Journal of Liver Cancer;2023-03-31

2. 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma;Clinical and Molecular Hepatology;2022-10-01

3. Phase II clinical trial of cabozantinib for the treatment of recurrent hepatocellular carcinoma after liver transplantation;Future Oncology;2022-06

4. 2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma;Korean Journal of Radiology;2022

5. Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements;Liver Cancer;2022